Literature DB >> 21645909

Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease.

Anne Tsampalieros1, Anne M Griffiths, Nick Barrowman, David R Mack.   

Abstract

C-reactive protein (CRP), a marker for inflammation, was evaluated with other routine blood tests in children with newly diagnosed inflammatory bowel disease. Evaluation of CRP level helped identify additional patients found to have inflammatory bowel disease at endoscopy, although a sizeable number of patients with mild ulcerative colitis had a normal CRP level.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645909     DOI: 10.1016/j.jpeds.2011.04.028

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Occult Blood and Perianal Examination: Value Added in Pediatric Inflammatory Bowel Disease Screening.

Authors:  Harland S Winter; Peter T Masiakos; Christopher J Moran; Jess L Kaplan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

2.  Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.

Authors:  Gea A Holtman; Yvonne Lisman-van Leeuwen; Andrew S Day; Ulrika L Fagerberg; Paul Henderson; Stevan T Leach; Gøri Perminow; David Mack; Patrick F van Rheenen; Els van de Vijver; David C Wilson; Johannes B Reitsma; Marjolein Y Berger
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 26.796

3.  Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD.

Authors:  Stephan Buderus; James H Boone; Michael J Lentze
Journal:  Gastroenterol Res Pract       Date:  2015-05-24       Impact factor: 2.260

4.  Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC.

Authors:  Amanda E Starr; Shelley A Deeke; Zhibin Ning; Cheng-Kang Chiang; Xu Zhang; Walid Mottawea; Ruth Singleton; Eric I Benchimol; Ming Wen; David R Mack; Alain Stintzi; Daniel Figeys
Journal:  Gut       Date:  2016-05-23       Impact factor: 23.059

5.  Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease.

Authors:  Suruchi K Batra; Christopher R Heier; Lina Diaz-Calderon; Christopher B Tully; Alyson A Fiorillo; John van den Anker; Laurie S Conklin
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

6.  Features and Outcomes of Children with Ulcerative Colitis who Undergo a Diagnostic Change: A Single-Center Experience.

Authors:  Natsuki Ito; Ichiro Takeuchi; Reiko Kyodo; Yuri Hirano; Takuro Sato; Masaaki Usami; Hirotaka Shimizu; Toshiaki Shimizu; Katsuhiro Arai
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-07-05

7.  Features of Intestinal Disease Associated With COVID-Related Multisystem Inflammatory Syndrome in Children.

Authors:  Benjamin Sahn; Ogechukwu P Eze; Morris C Edelman; Christina E Chougar; Rebecca M Thomas; Charles L Schleien; Toba Weinstein
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.